Daiichi Sankyo invests approximately one billion euros in Germany

– The research-based pharmaceutical company Daiichi Sankyo from Japan with European headquarters in Munich is expanding.
– In the future, the site in Pfaffenhofen will develop and produce therapies for the treatment of various cancers, including breast, lung, and stomach cancer, in addition to cardio…